MM Majumder
MM Majumder
Institute for Molecular Medicine Finland(FIMM), University of Helsinki
Verified email at - Homepage
Cited by
Cited by
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ...
New England Journal of Medicine 366 (20), 1905-1913, 2012
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia
T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ...
Cancer discovery 3 (12), 1416-1429, 2013
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
B Yadav, T Pemovska, A Szwajda, E Kulesskiy, M Kontro, R Karjalainen, ...
Scientific reports 4 (1), 1-10, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ...
Leukemia 28 (8), 1738-1742, 2014
Analgesic and antioxidant activity of the hydromethanolic extract of Mikania scandens (L.) Willd. leaves.
SMR Hasan, J Mariam, MM Majumder, A Raushanara, MM Hossain, ...
American Journal of Pharmacology and toxicology 4 (1), 1-7, 2009
Methylated DNA causes a physical block to replication forks independently of damage signalling, O6-methylguanine or DNA single-strand breaks and results in DNA damage
P Groth, S Ausländer, MM Majumder, N Schultz, F Johansson, ...
Journal of molecular biology 402 (1), 70-82, 2010
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
R Karjalainen, T Pemovska, M Popa, M Liu, KK Javarappa, MM Majumder, ...
Blood, The Journal of the American Society of Hematology 130 (6), 789-802, 2017
Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation
P Groth, ML Orta, I Elvers, MM Majumder, A Lagerqvist, T Helleday
Nucleic acids research 40 (14), 6585-6594, 2012
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
M Kontro, A Kumar, MM Majumder, S Eldfors, A Parsons, T Pemovska, ...
Leukemia 31 (2), 301-309, 2017
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer
A Malyutina, MM Majumder, W Wang, A Pessia, CA Heckman, J Tang
PLoS computational biology 15 (5), e1006752, 2019
Antidiarrhoeal property of the hydroethanolic extract of the flowering tops of Anthocephalus cadamba
MA Alam, R Akter, N Subhan, MM Rahman, MM Majumder, L Nahar, ...
Revista Brasileira de Farmacognosia 18, 155-159, 2008
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML
D Malani, A Murumägi, B Yadav, M Kontro, S Eldfors, A Kumar, ...
Leukemia 31 (5), 1187-1195, 2017
Evaluation of Analgesic and Antioxidant Potential of the Leaves of Curcuma alismatifolia Gagnep.
R Akter, SMR Hasan, SA Siddiqua, MM Majumder, MM Hossain, MA Alam, ...
Stamford Journal of Pharmaceutical Sciences 1 (1), 3-9, 2008
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing
MM Majumder, R Silvennoinen, P Anttila, D Tamborero, S Eldfors, ...
Oncotarget 8 (34), 56338, 2017
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
S Eldfors, H Kuusanmäki, M Kontro, MM Majumder, A Parsons, H Edgren, ...
Leukemia 31 (1), 51-57, 2017
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
JL Kivioja, A Thanasopoulou, A Kumar, M Kontro, B Yadav, MM Majumder, ...
Leukemia 33 (6), 1360-1372, 2019
Antioxidant and Membrane Stabilizing Properties of the Flowering Tops of Anthocephalus Cadamba
MA Alam, A Ghani, N Subhan, MM Rahman, MS Haque, MM Majumder, ...
Natural Product Communications 3 (1), 1934578X0800300114, 2008
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
PO Pietarinen, T Pemovska, M Kontro, B Yadav, JP Mpindi, EI Andersson, ...
Blood cancer journal 5 (5), e309-e309, 2015
The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
M Alzrigat, AA Párraga, MM Majumder, A Ma, J Jin, A Österborg, H Nahi, ...
Oncotarget 8 (61), 103731, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling
H Kuusanmäki, O Dufva, E Parri, AJ van Adrichem, H Rajala, ...
Oncotarget 8 (57), 97516, 2017
The system can't perform the operation now. Try again later.
Articles 1–20